[(3-Nitro-phenylamino)-phosphono-methyl]-phosphonic acid

ID: ALA450938

PubChem CID: 5277490

Max Phase: Preclinical

Molecular Formula: C7H10N2O8P2

Molecular Weight: 312.11

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=[N+]([O-])c1cccc(NC(P(=O)(O)O)P(=O)(O)O)c1

Standard InChI:  InChI=1S/C7H10N2O8P2/c10-9(11)6-3-1-2-5(4-6)8-7(18(12,13)14)19(15,16)17/h1-4,7-8H,(H2,12,13,14)(H2,15,16,17)

Standard InChI Key:  VPXZTOOBAWPNGR-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 19 19  0  0  0  0  0  0  0  0999 V2000
    3.1917   -1.1167    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9042   -0.7042    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
    3.1917   -1.9417    0.0000 P   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3750   -0.7167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.4792   -0.7042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3375   -1.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0500   -0.7125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3833    0.1083    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.9042    0.1208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.6042   -2.5250    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0958   -1.1292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7667   -1.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.3167   -1.4167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.7292   -0.7042    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0167   -1.9417    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.4042   -2.7375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3375   -1.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0500   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7667   -1.9542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  4  6  1  0
  5  1  1  0
  6  7  1  0
  7 12  2  0
  8  4  1  0
  9  2  2  0
 10  3  2  0
 11  4  2  0
 12  5  1  0
 13  2  1  0
 14  2  1  0
 15  3  1  0
 16  3  1  0
 17 18  1  0
 18 19  2  0
 19 12  1  0
  6 17  2  0
M  CHG  2   4   1   8  -1
M  END

Alternative Forms

Associated Targets(Human)

KB (17409 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hydroxyapatite (165 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP14 Tchem Matrix metalloproteinase 14 (1592 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP9 Tchem Matrix metalloproteinase 9 (6779 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP8 Tchem Matrix metalloproteinase 8 (1942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP2 Tchem Matrix metalloproteinase-2 (6627 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA1 Tclin Carbonic anhydrase I (13240 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA2 Tclin Carbonic anhydrase II (17698 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA9 Tclin Carbonic anhydrase IX (8255 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA12 Tclin Carbonic anhydrase XII (6231 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CA14 Tclin Carbonic anhydrase XIV (1305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

PPase1 Vacuolar-type proton translocating pyrophosphatase 1 (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HK Hexokinase (115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Dictyostelium discoideum (81 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PROC1 Pyrroline-5-carboxylate reductase (110 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
OSIGBa0132E09-OSIGBa0108L24.11 Glutamine synthetase (90 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 312.11Molecular Weight (Monoisotopic): 311.9912AlogP: 0.65#Rotatable Bonds: 5
Polar Surface Area: 170.23Molecular Species: ACIDHBA: 5HBD: 5
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: 0.95CX Basic pKa: CX LogP: 0.02CX LogD: -4.80
Aromatic Rings: 1Heavy Atoms: 19QED Weighted: 0.30Np Likeness Score: -0.96

References

1. Kotsikorou E, Song Y, Chan JM, Faelens S, Tovian Z, Broderick E, Bakalara N, Docampo R, Oldfield E..  (2005)  Bisphosphonate inhibition of the exopolyphosphatase activity of the Trypanosoma brucei soluble vacuolar pyrophosphatase.,  48  (19): [PMID:16162013] [10.1021/jm058220g]
2. Hudock MP, Sanz-Rodríguez CE, Song Y, Chan JM, Zhang Y, Odeh S, Kosztowski T, Leon-Rossell A, Concepción JL, Yardley V, Croft SL, Urbina JA, Oldfield E..  (2006)  Inhibition of Trypanosoma cruzi hexokinase by bisphosphonates.,  49  (1): [PMID:16392806] [10.1021/jm0582625]
3. Sanz-Rodríguez CE, Concepción JL, Pekerar S, Oldfield E, Urbina JA..  (2007)  Bisphosphonates as inhibitors of Trypanosoma cruzi hexokinase: kinetic and metabolic studies.,  282  (17): [PMID:17329254] [10.1074/jbc.m607286200]
4. Forlani G, Giberti S, Berlicki L, Petrollino D, Kafarski P..  (2007)  Plant P5C reductase as a new target for aminomethylenebisphosphonates.,  55  (11): [PMID:17474756] [10.1021/jf0701032]
5. Obojska A, Berlicki L, Kafarski P, Lejczak B, Chicca M, Forlani G..  (2004)  Herbicidal pyridyl derivatives of aminomethylene-bisphosphonic acid inhibit plant glutamine synthetase.,  52  (11): [PMID:15161194] [10.1021/jf049843q]
6. Tauro M, Laghezza A, Loiodice F, Agamennone M, Campestre C, Tortorella P..  (2013)  Arylamino methylene bisphosphonate derivatives as bone seeking matrix metalloproteinase inhibitors.,  21  (21): [PMID:24071448] [10.1016/j.bmc.2013.08.054]
7. Tauro M, Loiodice F, Ceruso M, Supuran CT, Tortorella P..  (2014)  Arylamino bisphosphonates: potent and selective inhibitors of the tumor-associated carbonic anhydrase XII.,  24  (8): [PMID:24650641] [10.1016/j.bmcl.2014.03.001]

Source